COSELA (Trilaciclib) First and Only Proactive Multilineage MyeloProtection

When:  Apr 14, 2022 from 18:00 to 20:00 (PT)
Associated with  National Capital
PLEASE JOIN US for this exciting new drug that has Myeloprotectant property

Date: Thursday, April 14th
Time: Registration at 6:00p Presentation 6:30p
Location: The Capital Grille (Bethesda)
Topic: Cosela (Trilaciclib) First and Only Proactive Multilineage MyeloProtection

PLEASE REGISTER TO: ANITA JOICE
email for registration: ajoice@g1therapeutics.com
phone number: (925) 260-9683

The indication for this product is to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide containing regimen or topotecan containing regimen for extensive cell lung cancer.

Location

The Capital Grille
5310 Western Avenue Northwest
Bethesda, MD 20815
Event Image

Contact

Anita Joice
(925) 260-9683
ajoice@g1therapeutics.com

Related Content